BRKR vs. TMDX

Last updated Jun 4, 2026

BRKR (Bruker Corporation) and TMDX (TransMedics Group, Inc.) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 5 years, BRKR returned -1.72%/yr vs 21.66%/yr for TMDX. At a 0.30 correlation, their price movements are largely independent.

Performance

BRKR vs. TMDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bruker Corporation (BRKR) and TransMedics Group, Inc. (TMDX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BRKR achieves a 33.29% return, which is significantly higher than TMDX's -42.71% return.

BRKR

• 1D: 9.40%
• 1M: 72.30%
• YTD: 33.29%
• 6M: 31.34%
• 1Y: 68.55%
• 3Y*: -3.88%
• 5Y*: -1.72%
• 10Y*: 9.48%

TMDX

• 1D: 1.81%
• 1M: -28.21%
• YTD: -42.71%
• 6M: -50.26%
• 1Y: -45.87%
• 3Y*: -2.02%
• 5Y*: 21.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BRKR vs. TMDX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
BRKR Bruker Corporation	33.29%	-19.24%	-19.99%	7.82%	-18.29%	55.35%	6.58%	32.43%
TMDX TransMedics Group, Inc.	-42.71%	95.11%	-21.01%	27.88%	222.13%	-3.72%	4.68%	-14.98%

Correlation

The correlation between BRKR and TMDX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.30
Correlation (All Time) Calculated using the full available price history since May 3, 2019	0.30

The correlation between BRKR and TMDX shifts across timeframes, from 0.16 (1 year) to 0.30 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap BRKR : $9.57B TMDX : $2.52B
EPS BRKR : -$0.17 TMDX : $4.34
PS Ratio BRKR : 2.76 TMDX : 4.34
PB Ratio BRKR : 3.88 TMDX : 5.11
Total Revenue (TTM) BRKR : $3.46B TMDX : $635.89M
Gross Profit (TTM) BRKR : $1.57B TMDX : $375.74M
EBITDA (TTM) BRKR : $224.20M TMDX : $125.51M

Return for Risk

BRKR vs. TMDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BRKR

BRKR Risk / Return Rank: 71
BRKR Sharpe Ratio Rank: 77
BRKR Sortino Ratio Rank: 72
BRKR Omega Ratio Rank: 70
BRKR Calmar Ratio Rank: 71
BRKR Martin Ratio Rank: 68

TMDX

TMDX Risk / Return Rank: 8
TMDX Sharpe Ratio Rank: 9
TMDX Sortino Ratio Rank: 11
TMDX Omega Ratio Rank: 11
TMDX Calmar Ratio Rank: 11
TMDX Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BRKR vs. TMDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bruker Corporation (BRKR) and TransMedics Group, Inc. (TMDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BRKR	TMDX	Difference
Sharpe ratio Return per unit of total volatility	1.26	-0.79	+2.06
Sortino ratio Return per unit of downside risk	1.86	-1.02	+2.88
Omega ratio Gain probability vs. loss probability	1.23	0.87	+0.36
Calmar ratio Return relative to maximum drawdown	1.73	-0.78	+2.51
Martin ratio Return relative to average drawdown	3.36	-1.99	+5.35
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BRKR vs. TMDX - Sharpe Ratio Comparison

The current BRKR Sharpe Ratio is 1.26, which is higher than the TMDX Sharpe Ratio of -0.79. The chart below compares the historical Sharpe Ratios of BRKR and TMDX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BRKR	TMDX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.26	-0.79	+2.06
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.04	0.30	-0.34
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.25	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.24	-0.17

Drawdowns

BRKR vs. TMDX - Drawdown Comparison

The maximum BRKR drawdown since its inception was -94.83%, which is greater than TMDX's maximum drawdown of -73.69%. Use the drawdown chart below to compare losses from any high point for BRKR and TMDX.

Drawdown Indicators

	BRKR	TMDX	Difference
Max Drawdown Largest peak-to-trough decline	-94.83%	-73.69%	-21.14%
Max Drawdown (1Y) Largest decline over 1 year	-39.85%	-58.76%	+18.91%
Max Drawdown (3Y) Largest decline over 3 years	-68.72%	-67.79%	-0.93%
Max Drawdown (5Y) Largest decline over 5 years	-68.72%	-67.79%	-0.93%
Max Drawdown (10Y) Largest decline over 10 years	-68.72%	—	—
Current Drawdown Current decline from peak	-32.90%	-60.43%	+27.53%
Average Drawdown Average peak-to-trough decline	-57.72%	-31.80%	-25.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.48%	23.09%	-2.61%

Volatility

BRKR vs. TMDX - Volatility Comparison

The current volatility for Bruker Corporation (BRKR) is 19.08%, while TransMedics Group, Inc. (TMDX) has a volatility of 29.84%. This indicates that BRKR experiences smaller price fluctuations and is considered to be less risky than TMDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BRKR	TMDX	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.08%	29.84%	-10.76%
Volatility (6M) Calculated over the trailing 6-month period	38.20%	43.73%	-5.53%
Volatility (1Y) Calculated over the trailing 1-year period	54.64%	58.11%	-3.47%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	41.36%	72.03%	-30.67%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.66%	71.74%	-34.08%

Dividends

BRKR vs. TMDX - Dividend Comparison

BRKR's dividend yield for the trailing twelve months is around 0.32%, while TMDX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
BRKR Bruker Corporation	0.32%	0.42%	0.34%	0.27%	0.29%	0.19%	0.30%	0.31%	0.54%	0.47%	0.76%
TMDX TransMedics Group, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

BRKR vs. TMDX - Profitability Comparison

The chart below illustrates the profitability comparison between Bruker Corporation and TransMedics Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BRKR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported a gross profit of 379.80M and revenue of 823.40M. Therefore, the gross margin over that period was 46.1%.

TMDX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a gross profit of 101.16M and revenue of 173.93M. Therefore, the gross margin over that period was 58.2%.

BRKR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported an operating income of 10.20M and revenue of 823.40M, resulting in an operating margin of 1.2%.

TMDX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported an operating income of 13.30M and revenue of 173.93M, resulting in an operating margin of 7.6%.

BRKR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported a net income of 0.00 and revenue of 823.40M, resulting in a net margin of 0.0%.

TMDX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a net income of 7.32M and revenue of 173.93M, resulting in a net margin of 4.2%.

Frequently Asked Questions

Can I hold both BRKR and TMDX in my portfolio?

BRKR and TMDX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BRKR or TMDX?

TMDX has higher volatility (29.84%) compared to BRKR (19.08%). In terms of maximum drawdown, BRKR dropped -94.83% vs TMDX's -73.69%.

Which has better risk-adjusted returns?

BRKR currently has the higher Sharpe Ratio (1.26 vs -0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.